NMR-Based Serum Metabolomics Discriminates Takayasu Arteritis from Healthy Individuals: A Proof-of-Principle Study

Journal of Proteome Research

Volumn 14, Issue 8, 2015, Pages 3372-3381

  Guleria, Anupam ^a   Misra, Durga Prasanna ^a   Rawat, Atul ^a   Dubey, Durgesh ^a   Khetrapal, Chunni Lal ^a   Bacon, Paul ^b   Misra, Ramnath ^a   Kumar, Dinesh ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

large vessel vasculitis; NMR based metabolomics; serum metabolites; Takayasu arteritis

Indexed keywords

CHOLINE; GLUCONIC ACID; GLUCOSE; GLYCOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LACTIC ACID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; N ACETYL GLYCOPROTEIN; UNCLASSIFIED DRUG; AMINO ACID; BIOLOGICAL MARKER; GLUCOSE BLOOD LEVEL; LACTIC ACID DERIVATIVE; LIPID;

ADULT; AMINO ACID BLOOD LEVEL; AORTA ARCH SYNDROME; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISCRIMINANT ANALYSIS; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; LACTATE BLOOD LEVEL; MALE; METABOLITE; METABOLOMICS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTON NUCLEAR MAGNETIC RESONANCE; BLOOD; DIFFERENTIAL DIAGNOSIS; METABOLISM; METABOLOME; MIDDLE AGED; PROCEDURES; RECEIVER OPERATING CHARACTERISTIC; REGRESSION ANALYSIS; REPRODUCIBILITY; TAKAYASU ARTERITIS; YOUNG ADULT;

ADULT; AMINO ACIDS; BIOMARKERS; BLOOD GLUCOSE; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CHOLINE; DIAGNOSIS, DIFFERENTIAL; DISCRIMINANT ANALYSIS; FEMALE; GLYCOPROTEINS; HUMANS; LACTATES; LEAST-SQUARES ANALYSIS; LIPIDS; MALE; METABOLOME; METABOLOMICS; MIDDLE AGED; PROTON MAGNETIC RESONANCE SPECTROSCOPY; REPRODUCIBILITY OF RESULTS; ROC CURVE; TAKAYASU ARTERITIS; YOUNG ADULT;

EID: 84938776219     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/acs.jproteome.5b00422     Document Type: Article

References (77)

1. Hotchi, M. Pathological studies on Takayasu arteritis Heart Vessels Suppl. 1992, 7, 11-17
2. Kerr, G. S.; Hallahan, C. W.; Giordano, J.; Leavitt, R. Y.; Fauci, A. S.; Rottem, M.; Hoffman, G. S. Takayasu arteritis Ann. Int. Med. 1994, 120, 919-929
3. Ishikawa, K. Natural history and classification of occlusive thromboaortopathy (Takayasus disease) Circulation 1978, 57, 27-35
4. Sharma, B. K.; Sagar, S.; Singh, A. P.; Suri, S. Takayasu arteritis in India Heart Vessels Suppl. 1992, 7, 37-43
5. Numano, F.; Okawara, M.; Inomata, H.; Kobayashi, Y. Takayasus arteritis Lancet 2000, 356, 1023-1025
6. Yilmaz, N.; Can, M.; Oner, F. A.; Kalfa, M.; Emmungil, H.; Karadag, O.; Yildiz, F.; Kimyon, G.; Yilmazer, B.; Gerdan, V.; Bilge, S. Y.; Ilhan, B.; Cobankara, V.; Kasifoglu, T.; Cefle, A.; Kisacik, B.; Onat, A. M.; Akar, S.; Onen, F.; Erken, E.; Kiraz, S.; Aksu, K.; Keser, G.; Mumcu, G.; Direskeneli, H. Impaired quality of life, disability and mental health in Takayasus arteritis Rheumatology 2013, 52, 1898-1904
7. Numano, F. Vasa vasoritis, vasculitis and atherosclerosis Int. J. Cardiol. 2000, 75, S1-S8
8. Numano, F.; Kishi, Y.; Tanaka, A.; Ohkawara, M.; Kakuta, T.; Kobayashi, Y. Inflammation and atherosclerosis. Atherosclerotic lesions in Takayasu arteritis Ann. N.Y. Acad. Sci. 2000, 902, 65-76
9. Manocha, D.; Anand, R.; Mehta, P.; Kumar, K.; Dewan, R. Atypical presentation of a young female patient with Takayasu arteritis: case report and review of literature Int. J. Clin. Pediatr. 2013, 2, 34-36
10. Liang, P.; Hoffman, G. S. Advances in the medical and surgical treatment of Takayasu arteritis Curr. Opin. Rheumatol. 2005, 17, 16-24
11. Mason, J. C. Takayasu arteritis-advances in diagnosis and management Nat. Rev. Rheumatol. 2010, 6, 406-415
12. Basu, N.; McClean, A.; Harper, L.; Amft, E. N.; Dhaun, N.; Luqmani, R. A.; Little, M. A.; Jayne, D. R. W.; Flossmann, O.; McLaren, J.; Kumar, V.; Erwig, L. P.; Reid, D. M.; Macfarlane, G. J.; Jones, G. T. Explaining fatigue in ANCA-associated vasculitis Rheumatology 2013, 52, 1680-1685
13. 18F-FDG PET/CT in inflammation of unknown origin Clin. Nucl. Med. 2014, 39, 419-425
14. 18F-FDG PET/CT in large-vessel vasculitis: appropriateness of current classification criteria? Biomed. Res. Int. 2014, 2014, 687608
15. Treglia, G.; Mattoli, M.; Leccisotti, L.; Ferraccioli, G.; Giordano, A. Usefulness of whole-body fluorine-18-fluorodeoxyglucose positron emission tomography in patients with large-vessel vasculitis: a systematic review Clin. Rheumatol. 2011, 30, 1265-1275
16. Soussan, M.; Nicolas, P.; Schramm, C.; Katsahian, S.; Pop, G.; Fain, O.; Mekinian, A. Management of large-vessel vasculitis with FDG-PET: a systematic literature review and meta-analysis Medicine 2015, 94, e622
17. Nicholson, J. K.; Lindon, J. C.; Holmes, E. Metabonomics: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data Xenobiotica 1999, 29, 1181-1189
18. Shanaiah, N.; Zhang, S.; Desilva, M. A.; Raftery, D. NMR-based metabolomics for biomarker discovery. In Biomarker Methods in Drug Discovery and Development; Wang, F., Ed.; Humana Press: Totowa, NJ, 2008; pp 341-368.
19. Gowda, G. A.; Zhang, S.; Gu, H.; Asiago, V.; Shanaiah, N.; Raftery, D. Metabolomics-based methods for early disease diagnostics Expert Rev. Mol. Diagn. 2008, 8, 617-633
20. Bartel, J.; Krumsiek, J.; Theis, F. J. Statistical methods for the analysis of high-throughput metabolomics data Comput. Struct. Biotechnol. J. 2013, 4, e201301009
21. Spratlin, J. L.; Serkova, N. J.; Eckhardt, S. G. Clinical applications of metabolomics in oncology: a review Clin. Cancer Res. 2009, 15, 431-440
22. Raamsdonk, L. M.; Teusink, B.; Broadhurst, D.; Zhang, N.; Hayes, A.; Walsh, M. C.; Berden, J. A.; Brindle, K. M.; Kell, D. B.; Rowland, J. J.; Westerhoff, H. V.; van Dam, K.; Oliver, S. G. A functional genomics strategy that uses metabolome data to reveal the phenotype of silent mutations Nat. Biotechnol. 2001, 19, 45-50
23. Nicholson, J.; Connelly, J.; Lindon, J.; Holmes, E. Metabonomics: a platform for studying drug toxicity and gene function Nat. Rev. Drug Discovery 2002, 1, 153-161
24. Griffin, J. L.; Atherton, H.; Shockcor, J.; Atzori, L. Metabolomics as a tool for cardiac research Nat. Rev. Cardiol. 2011, 8, 630-643
25. Slupsky, C. M.; Steed, H.; Wells, T. H.; Dabbs, K.; Schepansky, A.; Capstick, V.; Faught, W.; Sawyer, M. B. Urine metabolite analysis offers potential early diagnosis of ovarian and breast cancers Clin. Cancer Res. 2010, 16, 5835-5841
26. Armitage, E. G.; Barbas, C. Metabolomics in cancer biomarker discovery: current trends and future perspectives J. Pharm. Biomed. Anal. 2014, 87, 1-11
27. Vermeersch, K. A.; Styczynski, M. P. Applications of metabolomics in cancer research J. Carcinog. 2013, 12, 9
28. Serkova, N. J.; Glunde, K. Metabolomics of cancer Methods Mol. Biol. 2009, 520, 273-295
29. Lindon, J. C.; Nicholson, J. K.; Everett, J. R. NMR spectroscopy of biofluids Annu. Rep. NMR Spectrosc. 1999, 38, 1-88
30. Patti, G. J.; Yanes, O.; Siuzdak, G. Innovation: Metabolomics: the apogee of the omics trilogy Nat. Rev. Mol. Cell Biol. 2012, 13, 263-269
31. Arend, W. P.; Michel, B. A.; Bloch, D. A.; Hunder, G. G.; Calabrese, L. H.; Edworthy, S. M.; Fauci, A. S.; Leavitt, R. Y.; Lie, J. T.; Lightfoot, R. W., Jr. The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis Arthritis. Rheum. 1990, 33, 1129-1134
32. Misra, R.; Danda, D.; Rajappa, S. M.; Ghosh, A.; Gupta, R.; Mahendranath, K. M.; Jeyaseelan, L.; Lawrence, A.; Bacon, P. A. Development and initial validation of the Indian Takayasu clinical activity score (ITAS2010) Rheumatology 2013, 52, 1795-1801
33. Hori, S.; Nishiumi, S.; Kobayashi, K.; Shinohara, M.; Hatakeyama, Y.; Kotani, Y.; Hatano, N.; Maniwa, Y.; Nishio, W.; Bamba, T.; Fukusaki, E.; Azuma, T.; Takenawa, T.; Nishimura, Y.; Yoshida, M. A metabolomic approach to lung cancer Lung Cancer 2011, 74, 284-292
34. Nishiumi, S.; Kobayashi, T.; Ikeda, A.; Yoshie, T.; Kibi, M.; Izumi, Y.; Okuno, T.; Hayashi, N.; Kawano, S.; Takenawa, T.; Azuma, T.; Yoshida, M. A novel serum metabolomics-based diagnostic approach for colorectal cancer PLoS One 2012, 7, e40459
35. Wishart, D. S. Quantitative metabolomics using NMR Trends Anal. Chem. 2008, 27, 228-237
36. Xia, J.; Bjorndahl, T. C.; Tang, P.; Wishart, D. S. MetaboMiner-semi-automated identification of metabolites from 2D NMR spectra of complex biofluids BMC Bioinf. 2008, 9, 507
37. Jewison, T.; Knox, C.; Neveu, V.; Djoumbou, Y.; Guo, A. C.; Lee, J.; Liu, P.; Mandal, R.; Krishnamurthy, R.; Sinelnikov, I.; Wilson, M.; Wishart, D. S. YMDB: the Yeast Metabolome Database Nucleic Acids Res. 2012, 40, D815-D820
38. Psychogios, N.; Hau, D. D.; Peng, J.; Guo, A. C.; Mandal, R.; Bouatra, S.; Sinelnikov, I.; Krishnamurthy, R.; Eisner, R.; Gautam, B.; Young, N.; Xia, J.; Knox, C.; Dong, E.; Huang, P.; Hollander, Z.; Pedersen, T. L.; Smith, S. R.; Bamforth, F.; Greiner, R.; McManus, B.; Newman, J. W.; Goodfriend, T.; Wishart, D. S. The human serum metabolome PLoS One 2011, 6, e16957
39. Wishart, D. S.; Jewison, T.; Guo, A. C.; Wilson, M.; Knox, C.; Liu, Y.; Djoumbou, Y.; Mandal, R.; Aziat, F.; Dong, E.; Bouatra, S.; Sinelnikov, I.; Arndt, D.; Xia, J.; Liu, P.; Yallou, F.; Bjorndahl, T.; Perez-Pineiro, R.; Eisner, R.; Allen, F.; Neveu, V.; Greiner, R.; Scalbert, A. HMDB 3.0-the Human Metabolome Database in 2013 Nucleic Acids Res. 2013, 41, D801-D807
40. Guo, A. C.; Jewison, T.; Wilson, M.; Liu, Y.; Knox, C.; Djoumbou, Y.; Lo, P.; Mandal, R.; Krishnamurthy, R.; Wishart, D. S. ECMDB: the E. coli Metabolome Database Nucleic Acids Res. 2013, 41, D625-D630
41. Scrivo, R.; Casadei, L.; Valerio, M.; Priori, R.; Valesini, G.; Manetti, C. Metabolomics approach in allergic and rheumatic diseases Curr. Allergy Asthma Rep. 2014, 14, 445
42. Naughton, D.; Whelan, M.; Smith, E. C.; Williams, R.; Blake, D. R.; Grootveld, M. An investigation of the abnormal metabolic status of synovial fluid from patients with rheumatoid arthritis by high field proton nuclear magnetic resonance spectroscopy FEBS. Lett. 1993, 317, 135-138
43. Wu, T.; Xie, C.; Han, J.; Ye, Y.; Weiel, J.; Li, Q.; Blanco, I.; Ahn, C.; Olsen, N.; Putterman, C.; Saxena, R.; Mohan, C. Metabolic disturbances associated with systemic lupus erythematosus PLoS One 2012, 7, e37210
44. Kapoor, S.; Fitzpatrick, M.; Clay, E.; Bayley, R.; Wallace, G. R.; Young, S. P. Metabolomics in the analysis of inflammatory diseases. In Metabolomics; Roessner, U., Ed.; InTech: Rijeka, Croatia, 2012; pp 269-288.
45. Wang, X.; Chen, B.; Lv, N.; Liu, Q.; Dang, A. Association of abnormal lipid spectrum with the disease activity of Takayasu arteritis Clin. Rheumatol. 2015, 34, 1243-1248
46. Sun, L.; Hu, W.; Liu, Q.; Hao, Q.; Sun, B.; Zhang, Q.; Mao, S.; Qiao, J.; Yan, X. Metabonomics reveals plasma metabolic changes and inflammatory marker in polycystic ovary syndrome patients J. Proteome Res. 2012, 11, 2937-2946
47. 1H NMR-based metabolomic study of metabolic profiling for systemic lupus erythematosus Lupus 2011, 20, 1411-1420
48. Rav-Acha, M.; Plot, L.; Peled, N.; Amital, H. Coronary involvement in Takayasus arteritis Autoimmun. Rev. 2007, 6, 566-571
49. Goldstein, L. J.; Brown, S. M. The low-density lipoprotein pathway and its relation to atherosclerosis Annu. Rev. Biochem. 1977, 46, 897-930
50. Soufi, M.; Sattler, A. M.; Maisch, B.; Schaefer, J. R. Molecular mechanisms involved in atherosclerosis Herz 2002, 27, 637-648
51. Zeisel, S. H.; Blusztajn, J. K. Choline and human nutrition Annu. Rev. Nutr. 1994, 14, 269-296
52. 1H NMR based metabonomics approach to progression of coronary atherosclerosis in a hamster model Yaoxue Xuebao 2013, 48, 495-502
53. Guma, M.; Sanchez-Lopez, E.; Lodi, A.; Garcia-Carbonell, R.; Tiziani, S.; Karin, M.; Lacal, J. C.; Firestein, G. S. Choline kinase inhibition in rheumatoid arthritis Ann. Rheum. Dis. 2015, 74, 1399-1407
54. Parrish, W. R.; Rosas-Ballina, M.; Gallowitsch-Puerta, M.; Ochani, M.; Ochani, K.; Yang, L. H.; Hudson, L.; Lin, X.; Patel, N.; Johnson, S. M.; Chavan, S.; Goldstein, R. S.; Czura, C. J.; Miller, E. J.; Al-Abed, Y.; Tracey, K. J.; Pavlov, V. A. Modulation of TNF release by choline requires alpha7 subunit nicotinic acetylcholine receptor-mediated signaling Mol. Med. 2008, 14, 567-574
55. Buchman, A. L.; Jenden, D.; Roch, M. Plasma free, phospholipid-bound and urinary free choline all decrease during a marathon run and may be associated with impaired performance J. Am. Coll. Nutr. 1999, 18, 598-601
56. Bianchi, L.; De, M. E.; Bricolo, A.; Ballini, C.; Fattori, M.; Venturi, C.; Pedata, F.; Tipton, K. F.; Della, C. L. Extracellular levels of amino acids and choline in human high grade gliomas: an intraoperative microdialysis study Neurochem. Res. 2004, 29, 325-334
57. Glunde, K.; Shah, T.; Winnard, P. T., Jr.; Raman, V.; Takagi, T.; Vesuna, F.; Artemov, D.; Bhujwalla, Z. M. Hypoxia regulates choline kinase expression through hypoxia-inducible factor-1 alpha signaling in a human prostate cancer model Cancer Res. 2008, 68, 172-180
58. Glunde, K.; Bhujwalla, Z. M.; Ronen, S. M. Choline metabolism in malignant transformation Nat. Rev. Cancer 2011, 11, 835-848
59. Danne, O.; Mockel, M.; Lueders, C.; Mugge, C.; Zschunke, G. A.; Lufft, H.; Muller, C.; Frei, U. Prognostic implications of elevated whole blood choline levels in acute coronary syndromes Am. J. Cardiol. 2003, 91, 1060-1067
60. Danne, O.; Lueders, C.; Storm, C.; Frei, U.; Mockel, M. Whole blood choline and plasma choline in acute coronary syndromes: prognostic and pathophysiological implications Clin. Chim. Acta 2007, 383, 103-109
61. Danne, O.; Mockel, M. Choline in acute coronary syndrome: an emerging biomarker with implications for the integrated assessment of plaque vulnerability Expert Rev. Mol. Diagn. 2010, 10, 159-171
62. Konstantinova, S. V.; Tell, G. S.; Vollset, S. E.; Nygard, O.; Bleie, O.; Ueland, P. M. Divergent associations of plasma choline and betaine with components of metabolic syndrome in middle age and elderly men and women J. Nutr. 2008, 138, 914-920
63. Bye, A.; Vettukattil, R.; Aspenes, S. T.; Giskeødegård, G. F.; Gribbestad, I. S.; Wisløff, U.; Bathen, T. F. Serum levels of choline-containing compounds are associated with aerobic fitness level: the HUNT-study PLoS One 2012, 7, e42330
64. Tetlow, L. C.; Woolley, D. E. Histamine stimulates the proliferation of human articular chondrocytes in vitro and is expressed by chondrocytes in osteoarthritic cartilage Ann. Rheum. Dis. 2003, 62, 991-994
65. Wade, A. M.; Tucker, H. N. Antioxidant characteristics of l -histidine J. Nutr. Biochem. 1998, 9, 308-315
66. Watanabe, M.; Suliman, M. E.; Qureshi, A. R.; Garcia-Lopez, E.; Barany, P.; Heimburger, O.; Stenvinkel, P.; Lindholm, B. Consequences of low plasma histidine in chronic kidney disease patients: associations with inflammation, oxidative stress, and mortality Am. J. Clin. Nutr. 2008, 87, 1860-1866
67. Bell, J. D.; Brown, J. C.; Nicholson, J. K.; Sadler, P. J. Assignment of resonances for acute-phase glycoproteins in high resolution proton NMR spectra of human blood plasma FEBS Lett. 1987, 215, 311-315
68. Arnold, J. N.; Saldova, R.; Hamid, U. M.; Rudd, P. M. Evaluation of the serum N-linked glycome for the diagnosis of cancer and chronic inflammation Proteomics 2008, 8, 3284-3293
69. Schultz, D. R.; Arnold, P. I. Properties of four acute phase proteins: C-reactive protein, serum amyloid A protein, alpha 1-acid glycoprotein, and fibrinogen Semin. Arthritis Rheum. 1990, 20, 129-147
70. Williams, H. R.; Willsmore, J.; Cox, I. J.; Walker, D.; Cobbold, J.; Taylor-Robinson, S.; Orchard, T. Serum metabolic profiling in inflammatory bowel disease Dig. Dis. Sci. 2012, 57, 2157-2165
71. Lee, Y. S.; Choi, J. W.; Hwang, I.; Lee, J. W.; Lee, J. H.; Kim, A. Y.; Huh, J. Y.; Koh, Y. J.; Koh, G. Y.; Son, H. J.; Masuzaki, H.; Hotta, K.; Alfadda, A. A.; Kim, J. B. Adipocytokine orosomucoid integrates inflammatory and metabolic signals to preserve energy homeostasis by resolving immoderate inflammation J. Biol. Chem. 2010, 285, 22174-22185
72. Berenbaum, F.; Gars, L.Le; Toussirot, E.; Sanon, E.; Bories, C.; Kaplan, G.; Loiseau, P. M. Marked elevation of serum N-acetyl- d -hexosaminidase activity in rheumatoid arthritis Clin. Exp. Rheumatol. 2000, 18, 63-66
73. Nishida, K.; Nagamura, Y.; Ogitsu, N.; Ishiguro, I.; Ito, M. Change in levels of specific terminal sugar residues of glycoproteins in sera of patients with complication of diabetes and liver injury Rinsho Byori 1990, 38, 835-837
74. Itoh, N.; Sakaue, S.; Nakagawa, H.; Kurogochi, M.; Ohira, H.; Deguchi, K.; Nishimura, S.; Nishimura, M. Analysis of N-glycan in serum glycoproteins from db/db mice and humans with type 2 diabetes Am. J. Physiol.: Endocrinol. Metab. 2007, 293, E1069-E1077
75. Unizony, S.; Stone, J. H.; Stone, J. R. New treatment strategies in large-vessel vasculitis Curr. Opin. Rheumatol. 2013, 25, 3-9
76. Numano, F.; Okawara, M.; Inomata, H.; Kobayashi, Y. Takayasus arteritis Lancet 2000, 356, 1023-1025
77. Eichhorn, J.; Sima, D.; Thiele, B.; Lindschau, C.; Turowski, A.; Schmidt, H.; Schneider, W.; Haller, H.; Luft, F. C. Anti-endothelial cell antibodies in Takayasu arteritis Circulation 1996, 94, 2396-2401